2 results
8-K
EX-99.2
STSA
Satsuma Pharmaceuticals Inc
20 Dec 22
Satsuma Pharmaceuticals Provides STS101 Development Program and Corporate Update
4:19pm
what ~50% of gepant Rx’s not refilled physicians have long desired in a within 60 days STS101 demonstrates favorable DHE product safety and tolerability
8-K
EX-99.1
STSA
Satsuma Pharmaceuticals Inc
30 Nov 22
Other Events
4:00pm
Rx’s not refilled physicians have long desired in a ü STS101 demonstrates favorable within 60 days DHE product safety and tolerability in long-term
- Prev
- 1
- Next